Therapy - BMT Transplantation
"Allogeneic Bone Marrow Transplantation (ALLO-BMT) for Hodgkin's (HD) and Non-Hodgkin's Lymphoma (NHL)."
Published in Blood Weekly, September 25th, 1995
According to an abstract submitted by the authors to joint meetings of the Midwestern and Eastern regions of the American Federation for Clinical Research, to be held September 28-30, 1995 and October 28, 1995, in Chicago, Illinois and Boston Massachusetts, "The superiority of alloBMT over autologous BMT for patients (pts) with relapsed or refractory HD/NHL remains unproven. The added toxicity of graft vs host disease (GVHD) may diminish the potential benefits of graft vs tumor activity and receiving marrow stem cells untreated by prior chemotherapy. During 1987-95, 24 adults (ages 18-60 yrs; median 36) underwent alloBMT for lymphoma after failure of standard chemotherapy. Eighteen had...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1995-09-25)
More Articles from Blood Weekly
- Conference Coverage/AATB
Association Approves Revised Tissue Banking Standards - Conference Coverage/AATB
No Final Proposed FDA Tissue Regulations Are in Sight - Blood Banking
FDA Approval of PLA To Test for HTLV-I Received - Blood Banking
Hospital Takes FDA Action Seriously, Vows To Correct Procedures - Commentary
When Good Can Be Better Than Best - Industry News/Clinical Trials
FDA Clearance Received To Begin Human Testing of Cancer Drug - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
